Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.20.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities
    Years Ended December 31,  
    2019     2018  
Deferred Tax Assets:            
Tax benefit of net operating loss carry-forward   $ 11,828,268     $ 6,465,826  
Depreciation and amortization     27,949       (5,102 )
Accrued liabilities     360,204       261,876  
Stock based compensation     34,493       -  
Interest Expense     -       740,285  
R&D Credit     851,413       393,165  
Total deferred tax assets     13,102,327       7,856,050  
Valuation allowance for deferred tax assets     (13,102,327 )     (7,856,050 )
Deferred tax assets, net of valuation allowance   $ -     $ -  
Summary of Valuation Allowance
    Years Ended December 31,  
    2019     2018  
Beginning of the year   $ 7,856,050     $ 4,726,411  
Change in valuation account     5,246,277       3,129,639  
End of the year   $ 13,102,327     $ 7,856,050  
Schedule of Effective Income Tax Rate Reconciliation
    Years Ended December 31,  
    2018     2018  
U.S. federal statutory rate     (21.0 )%     (21.0 )%
Federal true ups     0.8 %        
State taxes, net of federal benefit     (6.2 )%     (6.9 )%
Share-based compensation     - %     - %
Effect of U.S. tax law change     - %     - %
Change in valuation allowance     27.1 %     25.8 %
                 
Nondeductible expenses     0.5 %     2.0 %
R&D credit     (2.4 )%     (3.2 )%
Stock Options     - %     3.3 %
Foreign rate differential     (0.2 )%        
China liquidation     1.4 %        
Effective income tax rate     - %     - %